204 related articles for article (PubMed ID: 14592831)
21. CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins.
Wang ZX; Berson JF; Zhang TY; Cen YH; Sun Y; Sharron M; Lu ZH; Peiper SC
J Biol Chem; 1998 Jun; 273(24):15007-15. PubMed ID: 9614108
[TBL] [Abstract][Full Text] [Related]
22. Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux.
Melar M; Ott DE; Hope TJ
J Virol; 2007 Feb; 81(4):1773-85. PubMed ID: 17121788
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
[TBL] [Abstract][Full Text] [Related]
24. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry.
Gowthaman U; Jayakanthan M; Sundar D
BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S14. PubMed ID: 19091013
[TBL] [Abstract][Full Text] [Related]
27. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion.
Ou W; Silver J
Virology; 2006 Jul; 350(2):406-17. PubMed ID: 16507315
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
[TBL] [Abstract][Full Text] [Related]
29. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Gallo SA; Puri A; Blumenthal R
Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
[TBL] [Abstract][Full Text] [Related]
31. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
Xiao X; Norwood D; Feng YR; Moriuchi M; Jones-Trower A; Stantchev TS; Moriuchi H; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):139-46. PubMed ID: 10816382
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
33. Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase.
Wang Z; Zhou Z; Guo ZY; Chi CW
Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):358-62. PubMed ID: 20458450
[TBL] [Abstract][Full Text] [Related]
34. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.
Stantchev TS; Paciga M; Lankford CR; Schwartzkopff F; Broder CC; Clouse KA
Retrovirology; 2012 Dec; 9():97. PubMed ID: 23206338
[TBL] [Abstract][Full Text] [Related]
35. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
[TBL] [Abstract][Full Text] [Related]
36. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
[TBL] [Abstract][Full Text] [Related]
37. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
LaBranche CC; Hoffman TL; Romano J; Haggarty BS; Edwards TG; Matthews TJ; Doms RW; Hoxie JA
J Virol; 1999 Dec; 73(12):10310-9. PubMed ID: 10559349
[TBL] [Abstract][Full Text] [Related]
38. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
Edwards TG; Hoffman TL; Baribaud F; Wyss S; LaBranche CC; Romano J; Adkinson J; Sharron M; Hoxie JA; Doms RW
J Virol; 2001 Jun; 75(11):5230-9. PubMed ID: 11333905
[TBL] [Abstract][Full Text] [Related]
39. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
40. Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes.
Lokensgard JR; Gekker G; Peterson PK
Biochem Pharmacol; 2002 Mar; 63(6):1037-41. PubMed ID: 11931835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
